The Blood Grouping Reagents Market value per capita in Greece stood at $1.35 in 2023. Observing the trend since 2013, the market has shown fluctuations with a peak in 2014 and a general decline until 2023. The year-on-year variations for 2022 to 2023 indicate a slight decline of 0.73%, while the Compound Annual Growth Rate (CAGR) from 2018 to 2023 highlights a marginal decrease of approximately 0.70% annually.
Future trends to watch for include:
- Potential technological advancements and their impact on market growth.
- The influence of healthcare policies in Greece on market demand.
- Any changes in public health initiatives that may drive the need for increased blood grouping testing.
